Understanding cardiovascular risks in endometriosis patients

Endometriosis increases the risk of cardiovascular events.

Precision medicine enhances prostate cancer treatment with genetic profiling

Men with metastatic castration-resistant prostate cancer should be treated primarily with second-generation hormone drugs, which offer better treatment response and longer life expectancy than chemotherapy.

August 20, 2024

GSK to pay up to $2.2B to settle almost all Zantac-related court cases

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 10, 2024

Neurona raises $120M to take epilepsy cell therapy to late-stage development

Neurona Therapeutics has gathered $120 million in what is expected to be its last private financing round to wrap up an open-label study this year

February 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.